142.67M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research.

Similar securities

Based on sector and market capitalization

Report issue